Hypothalamic Obesity Clinical Trials

20 clinical trials for Hypothalamic Obesity across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756) — RECRUITING · PHASE3
• A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO) — RECRUITING · PHASE2
• A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment — RECRUITING · PHASE1
• Tirzepatide in PWS, HO and GNSO — RECRUITING · PHASE4
• Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity — RECRUITING · PHASE2
• A Trial of Setmelanotide in Acquired Hypothalamic Obesity — ACTIVE_NOT_RECRUITING · PHASE3
• Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy — COMPLETED · PHASE3
• A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity — COMPLETED · PHASE2
• Open-Label Study of Setmelanotide in Hypothalamic Obesity — COMPLETED · PHASE2
• Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study) — COMPLETED · NA
• The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study — OTHER · PHASE1
• Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO) — WITHDRAWN · PHASE2
• Intranasal Oxytocin in Hypothalamic Obesity — COMPLETED · PHASE2
• Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity — COMPLETED · PHASE3
• Neuromodulation for Hypothalamic Obesity — WITHDRAWN · NA
• Effects of Exenatide on Hypothalamic Obesity — COMPLETED · PHASE1
• A Personalized Program of Physical Activity and Diet for Hypothalamic Obesity — COMPLETED
• Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy — COMPLETED · PHASE2
• Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage — OTHER · NA
• A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients — COMPLETED · PHASE4

Refine this search